Global Drug-Device Combination Products Market Ins

2022-04-25
  • Detail
Global Drug-Device Combination Products Market Insights and Forecast to 2028

Drug-Device Combination Products market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Drug-Device Combination Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Infusion Pumps

- Orthopedic Combination Products

- Photodynamic Therapy Devices

- Transdermal Patches

- Drug Eluting Stents

- Wound Care Products

- Inhalers

- Other

Segment by Application

- Hospital

- Clinic

- Other

By Company

- Abbott

- Terumo Corporation

- Stryker Corporation

- Mylan

- Medtronic

- Allergan

- Boston Scientific

- Novartis

- BD

- Teleflex Incorporated

By Region

- North America

- - the United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Drug-Device Combination Products Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Drug-Device Combination Products Product Introduction
1.2 Market by Type
1.2.1 Global Drug-Device Combination Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Infusion Pumps
1.2.3 Orthopedic Combination Products
1.2.4 Photodynamic Therapy Devices
1.2.5 Transdermal Patches
1.2.6 Drug Eluting Stents
1.2.7 Wound Care Products
1.2.8 Inhalers
1.2.9 Other
1.3 Market by Application
1.3.1 Global Drug-Device Combination Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drug-Device Combination Products Sales Estimates and Forecasts 2017-2028
2.2 Global Drug-Device Combination Products Revenue Estimates and Forecasts 2017-2028
2.3 Global Drug-Device Combination Products Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drug-Device Combination Products Sales by Region
2.4.1 Global Drug-Device Combination Products Sales by Region (2017-2022)
2.4.2 Global Sales Drug-Device Combination Products by Region (2023-2028)
2.5 Global Drug-Device Combination Products Revenue by Region
2.5.1 Global Drug-Device Combination Products Revenue by Region (2017-2022)
2.5.2 Global Drug-Device Combination Products Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drug-Device Combination Products Sales by Manufacturers
3.1.1 Global Top Drug-Device Combination Products Manufacturers by Sales (2017-2022)
3.1.2 Global Drug-Device Combination Products Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug-Device Combination Products in 2021
3.2 Global Drug-Device Combination Products Revenue by Manufacturers
3.2.1 Global Drug-Device Combination Products Revenue by Manufacturers (2017-2022)
3.2.2 Global Drug-Device Combination Products Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drug-Device Combination Products Revenue in 2021
3.3 Global Drug-Device Combination Products Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drug-Device Combination Products Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug-Device Combination Products Sales by Type
4.1.1 Global Drug-Device Combination Products Historical Sales by Type (2017-2022)
4.1.2 Global Drug-Device Combination Products Forecasted Sales by Type (2023-2028)
4.1.3 Global Drug-Device Combination Products Sales Market Share by Type (2017-2028)
4.2 Global Drug-Device Combination Products Revenue by Type
4.2.1 Global Drug-Device Combination Products Historical Revenue by Type (2017-2022)
4.2.2 Global Drug-Device Combination Products Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drug-Device Combination Products Revenue Market Share by Type (2017-2028)
4.3 Global Drug-Device Combination Products Price by Type
4.3.1 Global Drug-Device Combination Products Price by Type (2017-2022)
4.3.2 Global Drug-Device Combination Products Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drug-Device Combination Products Sales by Application
5.1.1 Global Drug-Device Combination Products Historical Sales by Application (2017-2022)
5.1.2 Global Drug-Device Combination Products Forecasted Sales by Application (2023-2028)
5.1.3 Global Drug-Device Combination Products Sales Market Share by Application (2017-2028)
5.2 Global Drug-Device Combination Products Revenue by Application
5.2.1 Global Drug-Device Combination Products Historical Revenue by Application (2017-2022)
5.2.2 Global Drug-Device Combination Products Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drug-Device Combination Products Revenue Market Share by Application (2017-2028)
5.3 Global Drug-Device Combination Products Price by Application
5.3.1 Global Drug-Device Combination Products Price by Application (2017-2022)
5.3.2 Global Drug-Device Combination Products Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drug-Device Combination Products Market Size by Type
6.1.1 North America Drug-Device Combination Products Sales by Type (2017-2028)
6.1.2 North America Drug-Device Combination Products Revenue by Type (2017-2028)
6.2 North America Drug-Device Combination Products Market Size by Application
6.2.1 North America Drug-Device Combination Products Sales by Application (2017-2028)
6.2.2 North America Drug-Device Combination Products Revenue by Application (2017-2028)
6.3 North America Drug-Device Combination Products Market Size by Country
6.3.1 North America Drug-Device Combination Products Sales by Country (2017-2028)
6.3.2 North America Drug-Device Combination Products Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Drug-Device Combination Products Market Size by Type
7.1.1 Europe Drug-Device Combination Products Sales by Type (2017-2028)
7.1.2 Europe Drug-Device Combination Products Revenue by Type (2017-2028)
7.2 Europe Drug-Device Combination Products Market Size by Application
7.2.1 Europe Drug-Device Combination Products Sales by Application (2017-2028)
7.2.2 Europe Drug-Device Combination Products Revenue by Application (2017-2028)
7.3 Europe Drug-Device Combination Products Market Size by Country
7.3.1 Europe Drug-Device Combination Products Sales by Country (2017-2028)
7.3.2 Europe Drug-Device Combination Products Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drug-Device Combination Products Market Size by Type
8.1.1 Asia Pacific Drug-Device Combination Products Sales by Type (2017-2028)
8.1.2 Asia Pacific Drug-Device Combination Products Revenue by Type (2017-2028)
8.2 Asia Pacific Drug-Device Combination Products Market Size by Application
8.2.1 Asia Pacific Drug-Device Combination Products Sales by Application (2017-2028)
8.2.2 Asia Pacific Drug-Device Combination Products Revenue by Application (2017-2028)
8.3 Asia Pacific Drug-Device Combination Products Market Size by Region
8.3.1 Asia Pacific Drug-Device Combination Products Sales by Region (2017-2028)
8.3.2 Asia Pacific Drug-Device Combination Products Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drug-Device Combination Products Market Size by Type
9.1.1 Latin America Drug-Device Combination Products Sales by Type (2017-2028)
9.1.2 Latin America Drug-Device Combination Products Revenue by Type (2017-2028)
9.2 Latin America Drug-Device Combination Products Market Size by Application
9.2.1 Latin America Drug-Device Combination Products Sales by Application (2017-2028)
9.2.2 Latin America Drug-Device Combination Products Revenue by Application (2017-2028)
9.3 Latin America Drug-Device Combination Products Market Size by Country
9.3.1 Latin America Drug-Device Combination Products Sales by Country (2017-2028)
9.3.2 Latin America Drug-Device Combination Products Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Drug-Device Combination Products Market Size by Type
10.1.1 Middle East and Africa Drug-Device Combination Products Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drug-Device Combination Products Revenue by Type (2017-2028)
10.2 Middle East and Africa Drug-Device Combination Products Market Size by Application
10.2.1 Middle East and Africa Drug-Device Combination Products Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drug-Device Combination Products Revenue by Application (2017-2028)
10.3 Middle East and Africa Drug-Device Combination Products Market Size by Country
10.3.1 Middle East and Africa Drug-Device Combination Products Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drug-Device Combination Products Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Terumo Corporation
11.2.1 Terumo Corporation Corporation Information
11.2.2 Terumo Corporation Overview
11.2.3 Terumo Corporation Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Terumo Corporation Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Terumo Corporation Recent Developments
11.3 Stryker Corporation
11.3.1 Stryker Corporation Corporation Information
11.3.2 Stryker Corporation Overview
11.3.3 Stryker Corporation Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Stryker Corporation Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Stryker Corporation Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylan Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Medtronic
11.5.1 Medtronic Corporation Information
11.5.2 Medtronic Overview
11.5.3 Medtronic Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Medtronic Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Medtronic Recent Developments
11.6 Allergan
11.6.1 Allergan Corporation Information
11.6.2 Allergan Overview
11.6.3 Allergan Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Allergan Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Allergan Recent Developments
11.7 Boston Scientific
11.7.1 Boston Scientific Corporation Information
11.7.2 Boston Scientific Overview
11.7.3 Boston Scientific Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Boston Scientific Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Boston Scientific Recent Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Overview
11.8.3 Novartis Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Novartis Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis Recent Developments
11.9 BD
11.9.1 BD Corporation Information
11.9.2 BD Overview
11.9.3 BD Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 BD Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BD Recent Developments
11.10 Teleflex Incorporated
11.10.1 Teleflex Incorporated Corporation Information
11.10.2 Teleflex Incorporated Overview
11.10.3 Teleflex Incorporated Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teleflex Incorporated Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teleflex Incorporated Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drug-Device Combination Products Industry Chain Analysis
12.2 Drug-Device Combination Products Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug-Device Combination Products Production Mode & Process
12.4 Drug-Device Combination Products Sales and Marketing
12.4.1 Drug-Device Combination Products Sales Channels
12.4.2 Drug-Device Combination Products Distributors
12.5 Drug-Device Combination Products Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drug-Device Combination Products Industry Trends
13.2 Drug-Device Combination Products Market Drivers
13.3 Drug-Device Combination Products Market Challenges
13.4 Drug-Device Combination Products Market Restraints
14 Key Findings in The Global Drug-Device Combination Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Copyright © 2011 JIN SHI